Clinical, electrophysiological findings and evaluation of prognosis of patients with Guillain-Barré syndrome

Guillain-Barré syndrome (GBS) is an acute inflammatory polyneuropathycharacterized by frequent rapid progressive, ascending, symmetric weakness andareflexia. We aimed to evaluate the etiology, clinical and electrophysiologicalfindings with treatment and prognosis of the patients with GBS in our clinic.Patients who were diagnosed with GBS in our clinic between 2009 and 2017were evaluated retrospectively. The study included 20 female and 25 malepatients. The most frequent symptom was the absence of walking (95.5%).All of the patients had muscle weakness on examination; in addition to thathyperesthesia (31%), autonomic symptoms (13.3%), sensory loss (11.1%),ataxia (11.1%), bilateral facial nerve palsy (6.6%), oculomotor nerve palsy(2.2%), and multiple cranial nerve involvement (2.2%) were the otherdetected findings. Ventilation support was required in 6 cases (13.3%).Acute motor axonal neuropathy (AMAN) was found in 20 patients (44.5%),acute inflammatory demyelinating polyradiculoneuropathy (AIDP) was foundin 24 patients (53.3%), and acute motor and sensory axonal neuropathy(AMSAN) was only present in 1 patient (2.2%). Intravenous immunoglobulin(IVIG) was administered to 33 of the patients (73.3%). The mean hospitalstay was 8.4±3.5 (2-17 days), and the relationship between the duration ofhospital stay and the treatment given was statistically significant (p = 0.001).Complete remission was observed in 37 patients (82.3%) and the remaining5 children (11.1%) experienced incomplete recovery. Three patients (6.7%)died of treatment-resistant hypotension, arrhythmia and severe pulmonaryinfection. The short duration of neurological deficit following infection, clinicalstage of application, need for mechanical ventilation, dysautonomia, cranialnerve involvement, and current subtype were the negative prognostic factors.Although GBS is a self-limiting disease, early diagnosis and treatment arevery important to reduce hospital stay with morbidity and mortality. Patientsexpected to be at high risk should be monitored closely.

___

1. van Doorn PA, Ruts L, Jacobs BC. Clinical features, pathogenesis, and treatment of Guillain-Barré syndrome. Lancet Neurol 2008; 7: 939-950.

2. Visser LH, van der Meche FG, Meulstee J, et al. Cytomegalovirus infection and Guillain-Barre syndrome: The clinical, electrophysiologic, and prognostic features. Dutch Guillain-Barre Study Group. Neurology 1996; 47: 668-673.

3. Asbury AK. New concepts of Guillain-Barré syndrome. J Child Neurol 2000; 15: 183-191.

4. Susuki K, Koga M, Hirata K, Isogai E, Yuki N. A Guillain-Barré syndrome variant with prominent facial diplegia. J Neurol 2009; 256: 1899-1905.

5. Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain-Barre syndrome. Ann Neurol 1990; 27(Suppl): S21-S24.

6. Ryan MM. Guillain-Barre Syndrome in childhood. J Paediatr Child Health 2005; 41: 237-241.

7. Hung PL, Chang WN, Huang LT, et al. A clinical and electrophysiologic survey of childhood Guillain-Barré syndrome. Pediatr Neurol. 2004; 30: 86-91.

8. Soysal A, Aysal F, Calıskan B, et al. Clinicoelectrophysiological findings and prognosis of GuillainBarre´ syndrome 10 years experience. Acta. Neurol Scand 2011; 123: 181-186.

9. Gupta D, Nair M, Baheti NN, Sarma PS, Kuruvilla A; Diplomate-American Board.Electrodiagnostic and clinical aspects of Guillain-Barré syndrome: An analysis of 142 cases. J Clin Neuromuscul Dis 2008; 10:42-51.

10. van Koningsveld R, Steyerberg EW, Hughes RAC, Swan AV, van Doorn PA, Jacobs BC. A clinical prognostic scoring system of Guillain-Barré syndrome. Lancet Neurol 2007; 6: 589-594.

11. Rantala H, Uhari M, Niemela M. Occurence, clinical manifestations, and prognosis of Guillain-Barre Syndrome. Arch Dis Child 1991; 66: 706-708.

12. Rees JH, Thompson RO, Smeeton NC, Hughes RAC. Epidemiological study of Guillain-Barre Syndrome in south cast England. J Neurol Neurosurg Psychiatry 1998; 64: 74-77.

13. Emilia-Romagna Study Group on Clinical and Epidemiological Problems in Neurology. Guillain Barre syndrome variants in Emilio-Romagna, ltaly, 1992-3: incidence, clinical features and prognosis. J Neurol Neurosurg Psychiatry 1998; 65: 218-224.

14. Delanoe C, Sebire G, Landrieu P, Huault G, Metral S. Acute inflammatory demyelinating polyradiculopathy in children: Clinical and electrodiagnostic studies. Ann Neurol 1998; 44: 350-356.

15. Rantala H, Uhari M, Cherry JD, Shields WD. Risk factors of respiratory failure in children with GuillainBarré syndrome. Pediatr Neurol 1995; 13: 289-292.

16. Hicks CW, Kay B, Worley SE, Moodley M. A clinical picture of Guillain-Barré syndrome in children in the United States. J Child Neurol 2010; 25: 1504-1510.

17. Cuadrado JI, de Pedro Cuesta J, Ara JR, et al; Spanish GBS Epidemiological Study Group. Guillain- Barré syndrome in Spain, 1985–1997: epidemiological and public health view. Eur Neurol 2001; 46: 83-91.

18. Gensicke H, Datta AN, Dill P, Schindler C, Fischer D.. Increased incidence of Guillain-Barre syndrome after surgery. Eur J Neurol 2012; 19: 1239-1244.

19. Haber P , Sejvar J, Mikaeloff Y, DeStefano F. Vaccines and Guillain-Barré syndrome. Drug Saf 2009; 32: 309- 323.

20. Bradshaw DY, Jones HR Jr. Guillain-Barre syndrome in children: Clinical course, electrodiagnosis, and prognosis. Muscle Nerve 1992; 15: 500-506.

21. Teng HW, Sung JY. Ptosis as the initial presentation of Guillain-Barré syndrome. J Emerg Med 2012; 43: e283-e285.

22. Munsat TL, Barnes JE. Relation of multiple cranial nerve dysfunction to the Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry 1965; 28: 115-120.

23. Yu JY, Jung HY, Kim CH, Kim HS, Kim MO. Multiple cranial neuropathies without limb involvements: Guillain-Barre syndrome variant? Ann Rehabil Med 2013; 37: 740-744.

24. Okuyama H. Mechanism of increase of the cerebrospinal fluid (CSF) protein content in Guillain-Barre syndrome. Study using RISA in evaluation of diffusion within CSF cavity and transport of CSF to circulating plasms. Rinsho Shinkeigaku (Clin Neurol) 1975; 15: 817-826.

25. Hung PL, Chang WN, Huang LT, et al. A clinical and electrophysiologic survey of childhood Guillain-Barre syndrome. Pediatr Neurol 2004; 30: 86-91.

26. Vucic S, Kiernan MC, Cornblath DR. Guillain-Barre´ syndrome: an update. J Clin Neurosci 2009; 16: 733- 741.

27. Nagasawa K, Kuwabara S, Misawa S, et al. Electrophysiological subtypes and prognosis of childhood Guillain-Barre syndrome in Japan. Muscle Nerve 2006; 33: 766-770.

28. Lu JL, Sheikh KA, Wu HS, et al. Physiologic-pathologic correlation in Guillain-Barre syndrome in children. Neurology 2000; 54: 33-39.

29. McKhann GM, Cornblath DR, Griffin JW, et al. Acute motor axonal neuropathy: A frequent cause of acute flaccid paralysis in China. Ann Neurol 1993; 33: 333- 342.

30. Paradiso G, Tripoli J, Galicchio S, Fejerman N. Epidemiological, clinical, and electrodiagnostic findings in childhood Guillain-Barre syndrome: A reappraisal. Ann Neurol 1999; 46: 701-707.

31. Tekgul H, Serdaroglu G, Tutuncuoglu S. Outcome of axonal and demyelinating forms of Guillain-Barre syndrome in children. Pediatr Neurol 2003; 28: 295- 299.

32. Kalita J, Misra UK, Goyal G, Das M. Guillain-Barré syndrome: subtypes and predictors of outcome from India. J Peripher Nerv Syst 2014; 19: 36-43.

33. Jerris RC, Fields PI, Nicholson MA. Fecal culture for Campylobacter and related organisms. In: Garcia LS, Isenberg HD (eds). Clinical Microbiology Prosedures Handbook. (2nd ed), ASM Press, Washington D.C. 2010:3.8.2.1 – 3.8.2.16.

34. T.C. Sağlık Bakanlığı (Bulaşıcı Hastalıkların Sürveyansı ve Kontrolü Projesi TR0802.16-01 Avrupa Birliği ve Dünya Bankası desteği ile) (Akbaş E, Pr Danışmanı). Türkiye'de Bulaşıcı Hastalıkların Tanısında Mikrobiyoloji Laboratuvar Kapasitesi Mevcut Durum Değerlendirmesi: Anket - LabKap2012. XXXV. Türk Mikrobiyoloji Kongresi, Kuşadası, 4 Kasım 2012.

35. Ogawara K, Kuwabara S, Mori M, Hattori T, Koga M, Yuki N. Axonal Guillain-Barré syndrome: Relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan. Ann Neurol 2000; 48: 624-631.

36. Haupt WF. Recent advances of therapeutic apheresis in Guillain-Barre syndrome. Ther Apher 2000; 4: 271-274.

37. Plasma Exchange/Sandoglobulin Guillain-Barre syndrome Trial Group. Randomized trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barre syndrome. Lancet 1997; 349: 225-230.

38. Chen WH, Yeh JH, Chiu HC. Experience of double filtration plasmapheresis in the treatment of GuillainBarré syndrome. J Clin Apher 1999; 14: 126-129.

39. El-Bayoumi MA, El-Refaey AM, Abdelkader AM, ElAssmy MM, Alwakeel AA, El-Tahan HM. Comparison of intravenous immunoglobulin and plasma exchange in treatment of mechanically ventilated children with Guillain Barré syndrome: a randomized study. Crit Care 2011; 15: R164.

40. Korinthenberg R, Schessl J, Kirschner J. Clinical presentation and course of childhood GuillainBarré syndrome: a prospective multicentre study. Neuropediatrics 2007; 38: 10-17.

41. Dimario FJ Jr, Edwards C. Autonomic dysfunction in childhood Guillain-Barré syndrome. J Child Neurol 2012; 27: 581-586.

42. Samadi M, Kazemi B, Golzari Oskoui S, Barzegar M. Assessment of autonomic dysfunction in childhood guillain-barré syndrome. J Cardiovasc Thorac Res 2013; 5: 81-85.

43. van den Berg B, Bunschoten C, van Doorn PA, Jacobs BC. Mortality in Guillain-Barre syndrome. Neurology 2013; 80: 1650-1654.
Turkish Journal of Pediatrics-Cover
  • ISSN: 0041-4301
  • Yayın Aralığı: Yılda 6 Sayı
  • Başlangıç: 1958
  • Yayıncı: Hacettepe Üniversitesi Çocuk Sağlığı Enstitüsü Müdürlüğü
Sayıdaki Diğer Makaleler

Etiology of vaginal discharge in sexually inactive adolescents

Yasemin DÜZÇEKER, Sinem AKGÜL, Yasemin ÖZSÜREKÇİ, Orhan DERMAN, Ateş KARA, Nuray KANBUR

Evaluation of growth in children and adolescents after renal transplantation

Bahar BÜYÜKKARAGÖZ, Sevcan Azime BAKKALOĞLU, Ayşe Fitnat TUNCEL, Banu Kadıoğlu YILMAZ, Deniz KARCAALTINCABA, Hatice PAŞAOĞLU

Neonatal form of biotin-thiamine-responsive basal ganglia disease. Clues to diagnosis

Aydan DEĞERLİYURT, Mehmet GÜNDÜZ, Serdar CEYLANER, Özlem ÜNAL

Detection and molecular characterization of uncommon rotavirus group A genotype G12 among hospitalized children in Chennai

Ponnambalam ARUN, Kaveri KRİSHNASAMİ, Palani GUNASEKERAN, Gracy FATHİMA, Vidya PADMANABHAN

Comparison of i-gel, LMA-supreme, LMA-classic and LMAproseal as conduits of endotracheal intubation in newborns and infants: A manikin study

Aysun Ankay YILBAŞ, Betül BAŞARAN, Filiz ÜZÜMCÜGİL, Başak AKÇA, Murat İZGİ, Özgür CANBAY

The impact of 21-hydroxylase deficiency on cardiac repolarization changes in children with 21-hydroxylasedeficient congenital adrenal hyperplasia

Hüseyin Anıl KORKMAZ, Rahmi ÖZDEMİR, Mehmet KÜÇÜK, Cem KARADENİZ, Timur MEŞE, Behzat ÖZKAN

The relationship between prenatal testosterone and developmental stuttering in boys

Yunus Emre DÖNMEZ, Özlem ÖZCAN, Ayhan BİLGİÇ, Dilşad Yıldız MİNİKSAR

Clinical, electrophysiological findings and evaluation of prognosis of patients with Guillain-Barré syndrome

Betül KILIÇ, Serdal GÜNGÖR, Bilge ÖZGÖR

Hemophagocytic lymphohistiocytosis associated with oxcarbazepine

Serkan KIRIK, Hatice GÜNEŞ, Sadık YURTTUTAN, Nafiz SARIŞIK, Can ACIPAYAM, Yasemin KIRIK

Giant axonal neuropathy: A differential diagnosis of consideration

Pınar EDEM, Mert KARAKAYA, Brunhilde WİRTH, Tuncay Derya OKUR, Uluç YİŞ